An eNOS-like nanomaterial for specific reversal of cerebral ischemia-reperfusion injury
9.5
来源：
Nature
关键字：
AI brain science
发布时间：
2025-10-28 03:35
摘要：
The study presents a novel MoS2-based nitric oxide donor (MSNO) designed for the treatment of cerebral ischemia-reperfusion injury (CIRI). MSNO effectively penetrates the blood-brain barrier and targets ischemic brain tissue, demonstrating significant therapeutic effects in reducing neuronal damage and improving neurological function. The research highlights MSNO's ability to provide controlled release of nitric oxide while eliminating reactive oxygen species, thus addressing the complex pathological mechanisms of CIRI. With promising results in both efficacy and safety, MSNO represents a significant advancement in nanomedicine for cerebrovascular diseases.
原文：
查看原文
价值分投票
评分标准
新闻价值分采用0-10分制，综合考虑新闻的真实性、重要性、时效性、影响力等多个维度。
评分越高，表示该新闻的价值越大，越值得关注。
价值维度分析
domain_focus
1.0
business_impact
1.0
scientific_rigor
1.5
timeliness_innovation
1.5
investment_perspective
2.5
market_value_relevance
1.0
team_institution_background
0.5
technical_barrier_competition
1.0
关键证据
MSNO effectively reduces neuronal damage and death through its triple effect on CIRI.
The study shows that MSNO can significantly improve neurological function and reduce infarct size.
MSNO demonstrates excellent biocompatibility and safety in vivo.
真实性检查
否
AI评分总结
The study presents a novel MoS2-based nitric oxide donor (MSNO) designed for the treatment of cerebral ischemia-reperfusion injury (CIRI). MSNO effectively penetrates the blood-brain barrier and targets ischemic brain tissue, demonstrating significant therapeutic effects in reducing neuronal damage and improving neurological function. The research highlights MSNO's ability to provide controlled release of nitric oxide while eliminating reactive oxygen species, thus addressing the complex pathological mechanisms of CIRI. With promising results in both efficacy and safety, MSNO represents a significant advancement in nanomedicine for cerebrovascular diseases.